NASDAQ: HCP
Hashicorp Inc Stock

$34.33+0.02 (+0.06%)
Updated Jan 17, 2025
HCP Price
$34.33
Fair Value Price
-$33.73
Market Cap
$7.02B
52 Week Low
$21.50
52 Week High
$34.47
P/E
-57.22x
P/B
5.58x
P/S
10.52x
PEG
N/A
Dividend Yield
N/A
Revenue
$654.89M
Earnings
-$122.22M
Gross Margin
82.1%
Operating Margin
-18.28%
Profit Margin
-18.7%
Debt to Equity
0.35
Operating Cash Flow
$68M
Beta
2.15
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A

HCP Overview

HashiCorp, Inc. is a freemium software company that offers open-source tools and commercial products that enable developers, operators, and security professionals to provision, secure, run and connect cloud-computing infrastructure. HashiCorp's main product line consists of Vagrant, Packer, Terraform, Consul, Vault, Nomad, Serf, Sentinel, Boundary, and Waypoint. The company was founded in 2012 and is based in San Francisco, CA.

Zen Rating

Our proven quant model uses 115 proprietary factors, including AI, to determine HCP's potential to beat the market

BBuy
  • Stocks with a Zen Rating of Buy (B) had an average return of +19.88% per year. Learn More

Zen Rating Component Grades

D
Value
A
Growth
C
Momentum
C
Sentiment
C
Safety
C
Financials
A
Artificial Intelligence
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.

Industry: Software Infrastructure

Industry Rating
A
HCP
Ranked
#39 of 130

Top Ranked Stocks in Industry

Name / TickerPriceZen Rating
$30.59A
$32.20A
$21.83A
View Top Software Infrastructure Stocks

Be the first to know about important HCP news, forecast changes, insider trades & much more!

HCP News

Overview

Due Diligence Score

Industry Average (32)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how HCP scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

HCP ($34.33) is overvalued by 201.78% relative to our estimate of its Fair Value price of -$33.73 based on Discounted Cash Flow (DCF) modelling
Below Fair Value Valuation
HCP ($34.33) is not significantly undervalued (201.78%) relative to our estimate of its Fair Value price of -$33.73 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
HCP is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more HCP due diligence checks available for Premium users.

Valuation

HCP fair value

Fair Value of HCP stock based on Discounted Cash Flow (DCF)

Price
$34.33
Fair Value
-$33.73
Undervalued by
201.78%
HCP ($34.33) is overvalued by... subscribe to Premium to read more.
Below Fair Value Valuation
HCP ($34.33) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
HCP is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

HCP price to earnings (PE)

For valuing profitable companies with steady earnings

Company
-57.22x
Industry
44.04x
Market
30.45x

HCP price to book (PB)

For valuing companies that are loss-making or have lots of physical asset

Company
5.58x
Industry
11.47x
HCP is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

HCP's financial health

Profit margin

Revenue
$173.4M
Net Income
-$13.0M
Profit Margin
-7.5%
HCP's Earnings (EBIT) of -$119.74M... subscribe to Premium to read more.
Interest Coverage Financials
HCP's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$1.7B
Liabilities
$435.3M
Debt to equity
0.35
HCP's short-term assets ($1.55B) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
HCP's short-term assets ($1.55B) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
HCP's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
$38.2M
Investing
$90.6M
Financing
-$2.3M
HCP's operating cash flow ($68.03M)... subscribe to Premium to read more.
Debt Coverage Financials

HCP vs Software Infrastructure Stocks

TickerZen RatingMarket Cap1d %P/EP/B
HCPB$7.02B+0.06%-57.22x5.58x
PATHB$7.16B-2.47%-81.38x4.13x
SPSCB$7.18B-0.22%89.67x8.65x
SC$7.18B+0.54%-23.76x4.38x
WEXC$7.31B+0.04%23.03x4.36x

Hashicorp Stock FAQ

What is Hashicorp's quote symbol?

(NASDAQ: HCP) Hashicorp trades on the NASDAQ under the ticker symbol HCP. Hashicorp stock quotes can also be displayed as NASDAQ: HCP.

If you're new to stock investing, here's how to buy Hashicorp stock.

What is the 52 week high and low for Hashicorp (NASDAQ: HCP)?

(NASDAQ: HCP) Hashicorp's 52-week high was $34.47, and its 52-week low was $21.50. It is currently -0.41% from its 52-week high and 59.67% from its 52-week low.

How much is Hashicorp stock worth today?

(NASDAQ: HCP) Hashicorp currently has 204,447,369 outstanding shares. With Hashicorp stock trading at $34.33 per share, the total value of Hashicorp stock (market capitalization) is $7.02B.

Hashicorp stock was originally listed at a price of $85.19 in Dec 9, 2021. If you had invested in Hashicorp stock at $85.19, your return over the last 3 years would have been -59.7%, for an annualized return of -26.14% (not including any dividends or dividend reinvestments).

How much is Hashicorp's stock price per share?

(NASDAQ: HCP) Hashicorp stock price per share is $34.33 today (as of Jan 17, 2025).

What is Hashicorp's Market Cap?

(NASDAQ: HCP) Hashicorp's market cap is $7.02B, as of Jan 18, 2025.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Hashicorp's market cap is calculated by multiplying HCP's current stock price of $34.33 by HCP's total outstanding shares of 204,447,369.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.